C07D 307/80
Radicals substituted by oxygen atoms
C07D307/80 (Radicals substituted by oxygen atoms) appears on 541 US grants and 483 published applications in this corpus.
Search patents in C07D- Granted patents
- 541
- Published applications
- 483
- Assignees
- 335
- Inventors
- 1,713
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 7 | 0 |
| 1978 | 11 | 0 |
| 1979 | 9 | 0 |
| 1980 | 7 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 8 | 0 |
| 1985 | 2 | 0 |
| 1986 | 7 | 0 |
| 1987 | 5 | 0 |
| 1988 | 3 | 0 |
| 1989 | 12 | 0 |
| 1990 | 8 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 13 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 13 | 0 |
| 1999 | 14 | 0 |
| 2000 | 10 | 0 |
| 2001 | 15 | 6 |
| 2002 | 10 | 10 |
| 2003 | 11 | 20 |
| 2004 | 14 | 32 |
| 2005 | 10 | 19 |
| 2006 | 15 | 21 |
| 2007 | 10 | 18 |
| 2008 | 11 | 18 |
| 2009 | 15 | 18 |
| 2010 | 17 | 28 |
| 2011 | 9 | 17 |
| 2012 | 14 | 30 |
| 2013 | 23 | 29 |
| 2014 | 21 | 29 |
| 2015 | 22 | 24 |
| 2016 | 20 | 23 |
| 2017 | 18 | 18 |
| 2018 | 17 | 9 |
| 2019 | 11 | 16 |
| 2020 | 12 | 18 |
| 2021 | 12 | 10 |
| 2022 | 12 | 18 |
| 2023 | 8 | 13 |
| 2024 | 6 | 10 |
| 2025 | 10 | 18 |
| 2026 | 2 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oral complement factor D inhibitors24 Feb 2026US 12,558,341 B2BioCryst Pharmaceuticals, Inc.
- Methods of protecting against neurodegeneration17 Feb 2026US 12,552,763 B2BioVentures, LLC
- Aryl hydrocarbon receptor activators18 Nov 2025US 12,473,262 B2Oregon State University
- Synthesis of deuterated aldehydes28 Oct 2025US 12,454,502 B2Arizona Board of Regents On Behalf of Athe University of Arizona
- Compositions and methods for inhibiting group II intron RNA23 Sep 2025US 12,421,257 B2Yale University
- Methods for determining drug candidates20 Aug 2026US 2026/0245655 A1Mosaiques Diagnostics and Therapeutics AG
- Compound for treating gout or hyperuricemia16 Jul 2026US 2026/0200884 A1Arthrosi Therapeutics, Inc.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
- Advantageous benzofuran compositions for mental disorders or enhancement25 Jun 2026US 2026/0176243 A1Tactogen Inc
- Oral complement factor d inhibitors18 Jun 2026US 2026/0165999 A1BioCryst Pharmaceuticals, Inc.
Most cited
By later US patents
- Spiro compounds and their use as electroluminescence materials179US 5,840,217 AHoechst Aktiengesellschaft · 1998
- Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them101US 5,223,510 ASanofi · 1993
- Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs73US 5,607,966 AAlcon Laboratories, Inc. · 1997
- Contrast enhanced photolithography70US 4,942,113 APlessey Overseas Limited · 1990
- 2-phenylbenzo[B]furans, process for their manufacture and pharmaceutical preparations containing them69US 5,470,854 ASchering Corporation · 1995